FSA Says One Third o...
Culture Free ID and ...
26th May 2015 Content supplied by: POCARED Diagnostics Ltd
Novel Gram Stain Platform to be Presented at ASM 2015
POCARED Diagnostics Ltd an Israeli-based in-vitro diagnostic and pre-analytical technologies manufacturer with offices in the US have announced a breakthrough in pre-analytical technologies and systems with its novel Gram stain methodology. POCARED’s™ SP is a general purpose pre-analytical platform which concentrates samples. This is the first system that can perform both direct, automated Gram staining and sample concentration. The performance will be presented at the ASM 2015 General Meeting, May 30 to June 2 in New Orleans, LA
"The versatility of POCARED’s SP demonstrates how POCARED is revolutionizing laboratory practice. Our SP platform now offers an automated Gram stain in addition to sample concentration, purification and homogenization with second-to-none performance. POCARED’s SP is a general-use platform that has applications in many of the newer laboratory technologies" says Jonathan Gurfinkel, President and CEO of the company.
Addressing a market of annual 35 million tests in the US alone and more than double of that number worldwide, POCARED continues to develop solutions for high volume test types. POCARED’s SP will be exhibited in booth number 211 at the meeting. POCARED will demonstrate the platform that provides both gram stain and second to-none cell recovery, viability, and robust fractionation capabilities.
Date Published: 26th May 2015
Source article link: View
FSA Says One Third of
Culture Free ID and Antimicrobial